{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:02:52Z","timestamp":1759341772478},"reference-count":21,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T00:00:00Z","timestamp":1353888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology Research"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:p>Hair disorders that have been described in association with pegylated interferon\u2013ribavirin combination treatment include canities, hypertrichosis, telogen effluvium, and the most common cutaneous side\u2010effect by far, alopecia. Alopecia is a heterogeneous disease characterized by hair loss on the scalp or any hair\u2010bearing surface with a wide range of clinical presentations, from a single patch of hair loss to complete loss of hair on the entire body (alopecia universalis). Although some cases of reversible alopecia universalis associated with pegylated interferon\u2013ribavirin combination therapy have been reported in the published work, irreversible alopecia universalis has not yet been reported in relation to pegylated interferon and ribavirin combination treatment. For the first time, we report a case of irreversible alopecia universalis during pegylated interferon\u2013ribavirin combination therapy in a man infected with hepatitis C virus in the absence of clinical or biochemical evidence of immunological disorders or thyroid dysfunction at any time before, during or after antiviral therapy.<\/jats:p>","DOI":"10.1111\/j.1872-034x.2012.01036.x","type":"journal-article","created":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T19:21:39Z","timestamp":1353957699000},"page":"1248-1251","source":"Crossref","is-referenced-by-count":8,"title":["Irreversible alopecia universalis during treatment with pegylated interferon\u2013ribavirin for chronic hepatitis C virus infection: Case report and published work review"],"prefix":"10.1111","volume":"42","author":[{"given":"Barbara","family":"Omazzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Prada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmario","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Sacrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,11,26]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)07361-3"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22759"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2005.17.2.212"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32818b27e5"},{"key":"e_1_2_4_7_2","first-page":"579","article-title":"Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg\u2010IFN and ribavirin","volume":"16","author":"Demirturk N","year":"2006","journal-title":"Eur J Dermatol"},{"key":"e_1_2_4_8_2","first-page":"644","article-title":"Alopecia universalis following interferon Alfa\u20102b and ribavirin treatment for hepatitis C","volume":"3","author":"Midian\u2010Singh R","year":"2007","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_2_4_9_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1155\/2009\/651952","article-title":"A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin","volume":"23","author":"Mistry N","year":"2009","journal-title":"Can J Gastroenterol"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb01185.x"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/107999002760274890"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247518"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000065841"},{"key":"e_1_2_4_14_2","first-page":"483","volume-title":"Lever's Histopathology of the Skin","author":"Elder DE","year":"2005"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12365508"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00394-9"},{"key":"e_1_2_4_17_2","first-page":"364","article-title":"Alopecia Areata: autoimmune basis of hair loss","volume":"14","author":"Alexis AF","year":"2004","journal-title":"Eur J Dermatol"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1978.tb03759.x"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01340.x"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1270"},{"key":"e_1_2_4_21_2","first-page":"191","article-title":"Epidemiologic and genetic characteristics of alopecia areata (part 1)","volume":"20","author":"Alzolibani AA","year":"2011","journal-title":"Acta Dermatoven APA"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32832be7a5"}],"container-title":["Hepatology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1872-034X.2012.01036.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1872-034X.2012.01036.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T06:50:29Z","timestamp":1697352629000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1872-034X.2012.01036.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,26]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1872-034X.2012.01036.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1872-034x.2012.01036.x","archive":["Portico"],"relation":{},"ISSN":["1386-6346","1872-034X"],"issn-type":[{"value":"1386-6346","type":"print"},{"value":"1872-034X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,26]]}}}